But in-licensing is also key when examining these stocks. In fact, in-licensing deals might be the pharmaceutical industry’s preferred mode of business development these days — perhaps even ...

With the currently revolving door of directors at the federal Consumer Financial Protection Bureau (CFPB)—which may soon be on its fourth director ...

But there’s another underutilized strategy that entrepreneurs should consider, which is licensing. Licensing allows startups to generate capital, leverage industry expertise, and gain market ...